Deleting PTEN in CRC HCT116 cells leads to constant Akt activation, which in turn increases cell resistance to cytotoxic T cells in vitro, as well as to adoptively transferred murine splenocytes in vivo (Hähnel et al., 2008). The gene discussed is AKT1; the disease is colorectal carcinoma.